ACTRN12605000296639已完成2 期
Randomised placebo controlled study on the safety and efficacy of a herbal tonic for cessation of smoking - five week pilot study
CigArrest Pty ltd0 个研究点目标入组 60 人开始时间: 2005年9月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 25 Years 至 75 Years（—）
- 性别
- All
入选标准
- •1) 3 or more years as a smoker 2) Smoke greater than or equal to 20 cigarettes per day 3) Fagerstrom greater than or equal to 5 4) Exhaled carbon monoxide concentration greater than or equal to 10ppm 5) In good general health.
排除标准
- •1) Pregnant or lactating females or women likely to become prgnant during the study2) History of serious or unstable cardiac, renal, hypertensive, pulmonary, endocrine, neurologic or neuropsychiatric disorders 3) History of alcohol or substance abuse4) Regular use of any non-cigarette tobacco products5) Current use of other smoking cessation treatments6) Use of any complementary medicine smoking cessation products in the previous 6 months7) Clinically abnormal liver function at baseline8) Unwilling to comply with study protocol9) Subjects who have participated in another clinical trial in the last 30 days10) Any other condition which in the opinion of the investigators could compromise the study.
研究者
相似试验
已完成
不适用
Randomised placebo controlled trial on the safety and efficacy of a topical treatment for bilaternal chronic plaque psoriasis in adultsISRCTN74459383H BioJuven Pty Ltd (Australia)29
已完成
2 期
Randomised placebo controlled trial on the safety and efficacy of BSP-201 in osteoarthritisOsteoarthritis of the knees and/or hipsMusculoskeletal - OsteoarthritisACTRN12606000162516BSP Pharma A/S (this is the full name of company)128
尚未招募
2 期
Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritisOsteoarthritis of the knees and/or hipsMusculoskeletal - OsteoarthritisACTRN12606000024549Healtheries of New Zealand Ltd100
进行中（未招募）
不适用
A Placebo-Controlled Study to Evaluate the Safety and Efficacy of IPX066 in Subjects with Parkinson's DiseaseIdiopathic Parkinson's disease (paralysis agitans)MedDRA version: 9.1Level: LLTClassification code 10034010Term: ParkinsonismEUCTR2009-010193-38-LVIMPAX Laboratories, Inc.350
进行中（未招募）
不适用
A Placebo-Controlled Study to Evaluate the Safety and Efficacy of IPX066 in Subjects with Parkinson's DiseaseIdiopathic Parkinson's disease (paralysis agitans)MedDRA version: 9.1Level: LLTClassification code 10034010Term: ParkinsonismEUCTR2009-010193-38-EEIMPAX Laboratories, Inc.350